HTL was the proud sponsor of the IMCAS Innovation Tank
HTL is excited to highlight its participation in IMCAS 2023, a significant event that provided our team with a valuable opportunity to connect with our customers and esteemed partners.
During the event, we had the privilege of sharing insights into our innovative platform and discussing our ambitious future plans. This interaction not only reinforced our relationships but also allowed us to forge new collaborations that will play a role in shaping our company’s journey.
To see our most recent news,
![](https://htlbiotech.com/wp-content/uploads/2023/08/partner-1.jpg)
Read more
news from us
-
Articles July 5, 2024
HTL Biotechnology Secures Medical Device Registration in China
Sodium DNA Raw Material Main Document (Polynucleotides) registered as a medical device (number M2024199-000) in China.
-
Articles June 21, 2024
HTL Biotechnology at CPHI China 2024
CPHI China is one of Asia’s leading Pharma events for trading and networking with 3,500+ exhibitors and 90,000+ professionals from the pharmaceutical industry,
-
Articles June 13, 2024
Discover our Quality Policy
At HTL Biotechnology, we believe in going beyond together to achieve the highest quality standards.